Levothyroxine sodium

Product NDC: 68788-7944
Requested package NDC: 68788-7944-3
11-digit product format: 687887944
Labeler code: 68788
Product ID: 68788-7944_ba0471aa-e839-43e0-a807-e256c76df4d9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levothyroxine Sodium
Dosage form: TABLET
Route: ORAL
Labeler: Preferred Pharmaceuticals Inc.
Application: ANDA212399
Marketing category: ANDA
Marketing start: 2021-06-28
Substance: LEVOTHYROXINE SODIUM
Active strength: 137 ug/1
Pharmacologic classes: Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A212399-001	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-002	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-003	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-004	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-005	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-006	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-007	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-008	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-009	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-010	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-011	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19
A212399-012	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 48 matching rows.

Application-product, TE code table
Application-product	TE code
A212399-001	AB1
A212399-001	AB2
A212399-001	AB3
A212399-001	AB4
A212399-002	AB1
A212399-002	AB2
A212399-002	AB3
A212399-002	AB4
A212399-003	AB1
A212399-003	AB2
A212399-003	AB3
A212399-003	AB4
A212399-004	AB1
A212399-004	AB2
A212399-004	AB3
A212399-004	AB4
A212399-005	AB1
A212399-005	AB2
A212399-005	AB3
A212399-005	AB4
A212399-006	AB1
A212399-006	AB2
A212399-006	AB3
A212399-006	AB4
A212399-007	AB1
A212399-007	AB2
A212399-007	AB3
A212399-007	AB4
A212399-008	AB1
A212399-008	AB2
A212399-008	AB3
A212399-008	AB4
A212399-009	AB1
A212399-009	AB2
A212399-009	AB3
A212399-009	AB4
A212399-010	AB1
A212399-010	AB2
A212399-010	AB3
A212399-010	AB4
A212399-011	AB1
A212399-011	AB2
A212399-011	AB3
A212399-011	AB4
A212399-012	AB1
A212399-012	AB2
A212399-012	AB3
A212399-012	AB4

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A212399-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2020-10-19	`a50c72e98297…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 48 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A212399-001	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-001	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-001	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-001	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-002	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-002	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-002	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-002	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-003	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-003	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-003	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-003	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-004	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-004	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-004	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-004	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-005	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-005	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-005	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-005	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-006	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-006	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-006	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-006	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-007	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-007	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-007	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-007	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-008	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-008	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-008	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-008	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-009	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-009	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-009	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-009	AB4	4	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-010	AB1	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-010	AB2	2	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-010	AB3	3	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A212399-010	AB4	4	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 4 · 69 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	4f40db1e-3dd9-4c7b-93e6-64f0fd10d551	2026-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	6d65b528-f52b-4b5d-8b76-46fbd4576f99	2026-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399 ndc (package): 68788-7944-3 ndc (product): 68788-7944 ndc11 (package): 68788794403
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	c38c3c31-6834-4590-ace0-f525e5599f66	2026-05-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	83854522-f22e-491f-8392-c8b1f9441760	2026-05-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	633b3f9c-9578-4e07-a515-aec1a8b65e92	2026-05-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	0cffbc96-7a02-4538-9966-b69249be6eb2	2026-05-19	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	775ef7ba-0b5b-40ba-ac7b-2aef121fe4f4	2026-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	231fcdf8-c642-4074-8be8-53ee9c918f18	2026-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	251e65e0-6925-4984-9df9-d6d7c6d0703c	2026-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	741a8b30-86e1-4f37-917a-73265a82ee07	2026-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	4a2c8e57-d52d-409f-83d8-731b721bf613	2026-04-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	f347d92a-7726-4165-bc3c-f5b37ec86f9f	2026-04-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	REMEDYREPACK INC.	f8c14539-8ed1-406a-9b58-8ba3a7ce7ee3	2026-04-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	REMEDYREPACK INC.	55cebc88-0514-4940-b974-ec7f0467d10e	2026-04-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	REMEDYREPACK INC.	c7d5b71b-e983-4b1a-bfc2-d2343cf8668c	2026-04-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d	2026-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	70853a82-ba3b-4663-9f78-6791ca72ba9f	2026-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	7c8a6441-3c12-46ae-bb3b-a320d80045b6	2026-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	008de8fd-150f-4022-8ccb-c8bfa94875c7	2026-03-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	67f46137-afc4-471b-a6c7-9c2aef92da5d	2026-03-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212399 application number: ANDA212399

Additional Listing Data#

Finished product: Yes
Brand name base: Levothyroxine sodium
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVOTHYROXINE SODIUM	137 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9J765S329G	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
966270	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6d65b528-f52b-4b5d-8b76-46fbd4576f99	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
97c252d3-9bb8-4530-bb44-9824dc7cf556	Product name	6	20250729
6c43b71c-35e6-4db3-ba24-c6ef42ff7003	Product name	3	20240207
890fd4bf-1a80-42b7-be1b-2d0259d5f0c8	Product name	5	20240207
c8ad26bf-af73-460b-b74e-1eff16cc4f9f	Product name	5	20240207
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
01383843-4069-43cf-aa76-dc17a6f9f8c4	Product name	2	20230123
978cca7d-a938-4791-8322-da48d90a63ef	Product name	1	20230113
65f86ba3-8816-4e12-899b-18290c8de551	Product name	2	20210614
f16ab90f-08c2-40be-a543-66d9827cd1f3	Product name	1	20210601
6a33ec05-2ae2-45e5-ab82-2d94b3303923	Product name	1	20190709
93355a10-1c44-4c92-a11d-7d995e0200d9	Product name	1	20190219
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68788-7944-1	Levothyroxine sodium	100 in 1 BOTTLE	TABLET	100	6
68788-7944-3	Levothyroxine sodium	30 in 1 BOTTLE	TABLET	30	6
68788-7944-9	Levothyroxine sodium	90 in 1 BOTTLE	TABLET	90	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68788-7944-1	EA - Each	68788-7944	ef7bcfba-95f5-48d0-a9d1-3a2b2fb5210f	1	2022-11-07
68788-7944-3	EA - Each	68788-7944	5cc87cee-623c-4d3b-8419-6b2a8c05247e	1	2022-11-07
68788-7944-9	EA - Each	68788-7944	3e3dcb50-8a70-4b88-9d10-3f02548f9d1b	1	2022-11-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68788-7944	LEVOTHYROXINE SODIUM TABLET [PREFERRED PHARMACEUTICALS INC.]	4	Current NDC, Legacy NDC, 3 package rows	20240615_6d65b528-f52b-4b5d-8b76-46fbd4576f99.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9J765S329G	LEVOTHYROXINE SODIUM	6106-07-6	LEVOTHYROXINE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
966270	levothyroxine sodium 137 MCG Oral Tablet	PSN	6d65b528-f52b-4b5d-8b76-46fbd4576f99	6
966270	levothyroxine sodium 0.137 MG Oral Tablet	SCD	6d65b528-f52b-4b5d-8b76-46fbd4576f99	6
966270	levothyroxine sodium 137 MCG Oral Tablet	SY	6d65b528-f52b-4b5d-8b76-46fbd4576f99	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68788-7944-3	68788794403	30 TABLET in 1 BOTTLE (68788-7944-3)	30 tablet	2021-06-28	0000-00-00	No	No	Current